WEHI-842   Click here for help

GtoPdb Ligand ID: 10616

PDB Ligand Antimalarial Ligand
Compound class: Synthetic organic
Comment: WEHI-842 was developed as a potent peptidomimetic inhibitor of Plasmodium plasmepsin V (PMV), a promising target for antimalarial drug development [2].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 7
Rotatable bonds 25
Topological polar surface area 219.49
Molecular weight 669.38
XLogP 3.57
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NC(=NOCC[C@@H](C(=O)N[C@H](C(=O)N[C@H]([C@H](CC(=O)NCCc1ccccc1)O)CC(C)C)C(C)C)NC(=O)OCc1ccccc1)N
Isomeric SMILES NC(=NOCC[C@@H](C(=O)N[C@H](C(=O)N[C@H]([C@H](CC(=O)NCCc1ccccc1)O)CC(C)C)C(C)C)NC(=O)OCc1ccccc1)N
InChI InChI=1S/C34H51N7O7/c1-22(2)19-27(28(42)20-29(43)37-17-15-24-11-7-5-8-12-24)38-32(45)30(23(3)4)40-31(44)26(16-18-48-41-33(35)36)39-34(46)47-21-25-13-9-6-10-14-25/h5-14,22-23,26-28,30,42H,15-21H2,1-4H3,(H,37,43)(H,38,45)(H,39,46)(H,40,44)(H4,35,36,41)/t26-,27-,28-,30-/m0/s1
InChI Key VAHRPHLZONNTFF-NUISNXNRSA-N
Bioactivity Comments
WEHI-842 inhibits P. falciparum and P. vivax recombinant PMV with a IC50 of 0.2 nM and 0.4 nM respectively [2].
The interaction table below provides data from whole cell assays, giving the antiparasite activity of WEHI-842 against the asexual blood stage of the Plasmodium lifecycle and examining its transmission-blocking potential. The malaria parasite is sensitive to PMV inhibition at two points during the asexual blood stage; immediately after invasion and the early trophozoite [4]. WEHI-842 inhibits development of stage II-V gametocytes, while gametocytogenesis in the presence of sublethal inhibitor concentrations results in gametocytes that fail to infect mosquitoes [3].
Selectivity at other protein targets
Key to terms and symbols Click on species/strain names for details Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Plasmodium falciparum plasmepsin V Pf Inhibitor Inhibition 9.7 pIC50 - 2
pIC50 9.7 (IC50 2x10-10 M) [2]
Whole organism assay data
Key to terms and symbols Click on species/strain names for details Click column headers to sort
MOA/likely target Sp. Assay description Type Action Value Parameter Concentration range (M) Reference
Plasmodium falciparum plasmepsin V PfNF54 Parasite gametocyte assay - - 7.4 pEC50 - 3
pEC50 7.4 (EC50 4x10-8 M) Giemsa-stained blood film counts: no stage II-V gametocytes were observed [3]
Lifecycle stages: Plasmodium sexual blood stage (gametocyte)
Plasmodium falciparum plasmepsin V Pf3D7 Parasite growth inhibition assay - - 6.4 pEC50 - 2
pEC50 6.4 (EC50 4x10-7 M) [2]
Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
Plasmodium falciparum plasmepsin V PfNF54 Standard membrane feeding assay (SMFA) - - - - - 3
Oocyst count: WEHI-842 demonstrates a dose-dependent inhibitory effect on transmission fitness [3]
Lifecycle stages: Plasmodium mosquito host stage (gametocyte, gamete, zygote, ookinete, oocyst, sporozoite)